|
|
|
|
Long acting cabotegravir plus lenacapavir as a fully injectable maintenance antiretroviral regimen in people with HIV with adherence issues
|
|
|
Glasgow 2024 Nov 10-13
Romain Palich,1 Romain Manchon,2 Jérémy Zeggagh,2 Elisabete Gomes Pires,2 Marc Wirden,3 Marianne Burgard,4 Sophie Seang,1 Marc-Antoine Valantin,1 Gilles Peytavin,5 Claudine Duviver2,6
|
|
|
|
|
|
|